These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2550134)

  • 21. A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus.
    Hill JA; Hummel M; Starling RC; Kobashigawa JA; Perrone SV; Arizón JM; Simonsen S; Abeywickrama KH; Bara C
    Transplantation; 2007 Dec; 84(11):1436-42. PubMed ID: 18091519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperimmuneglobulin for cytomegalovirus prophylaxis following heart transplantation.
    Schäfers HJ; Wahlers T; Jurmann M; Fieguth HG; Milbradt H; Flik J; Haverich A
    J Hosp Infect; 1988 Aug; 12 Suppl D():61-5. PubMed ID: 2902131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infections in organ transplantations].
    Holzinger C; Buxbaum P; Laczkovics A; Domanig E; Wolner E
    Zentralbl Chir; 1990; 115(17):1091-9. PubMed ID: 2173865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modification of the incidence and course of CMV infections following kidney transplantation by passive immunization--initial experiences with a hyperimmunoglobulin].
    Hoyer J; Dennin RH; Schulz E
    Immun Infekt; 1985 Nov; 13(6):285-9. PubMed ID: 3000921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus prophylaxis by intravenous immunoglobulins in five heart transplanted patients.
    Tinelli M; Percivalle E; Zambelli A; Grossi P; Maccabruni A
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):459-67. PubMed ID: 1967092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequency and serologic diagnosis of cytomegalic infections following heart transplantation in 1986].
    Milbradt H; Schäfers HJ; Flik J
    Dtsch Med Wochenschr; 1987 Nov; 112(46):1779-81. PubMed ID: 2824163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary and secondary cytomegalovirus infection.
    Suwansirikul S; Rao N; Dowling JN; Ho M
    Arch Intern Med; 1977 Aug; 137(8):1026-9. PubMed ID: 195547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.
    Balk AH; Weimar W; Rothbarth PH; Meeter K; Metselaar HJ; Mochtar B; Simoons ML
    Infection; 1993; 21(4):195-200. PubMed ID: 8225620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients.
    Havel M; Teufelsbauer H; Laczkovics A; Kurz R; Wolner E
    Transplant Proc; 1990 Aug; 22(4):1805-6. PubMed ID: 2167533
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin.
    Metselaar HJ; Balk AH; Mochtar B; Rothbarth PH; Weimar W
    Chest; 1990 Feb; 97(2):396-9. PubMed ID: 2153508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study.
    Delgado JF; Manito N; Almenar L; Crespo-Leiro M; Roig E; Segovia J; Vázquez de Prada JA; Lage E; Palomo J; Campreciós M; Arizón JM; Rodríguez-Lambert JL; Blasco T; de la Fuente L; Pascual D; Rábago G
    Transpl Infect Dis; 2011 Apr; 13(2):136-44. PubMed ID: 21040280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytomegalovirus infection and chronic hemodialysis.
    Sexton DJ; Smith EW; Gutman RA; Helms MJ; Lang DJ
    Clin Nephrol; 1979 Jan; 11(1):3-6. PubMed ID: 218759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experiences with cytomegalovirus hyperimmunoglobulin after bone marrow transplantation].
    Schmitz N; Gassmann W; Rautenberg P; Löffler H
    Immun Infekt; 1985 Sep; 13(5):224-8. PubMed ID: 2998979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.